ReviewCurrent oncology (Toronto, Ont.)2022

Consensus Recommendations to Optimize Testing for New Targetable Alterations in Non-Small Cell Lung Cancer.

Diana N Ionescu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.